Good observation - how it helps us investors in AVXL?
Everyone knows ALZ opportunity is enormous - anyone who gets a good drug not even cure, will just make huge money
CELG gave money to PRTA for a compound that is has not filed an IND yet - so why they overlooked A2-73? The obvious answer is they did not believe in potential of A2-73